A r elsesser
Biotechnology
Drexel University
Czech Republic
Biography
has served as Chief Executive Officer and a member of our board of directors since our inception in 2004, and as President and Chairman of our board of directors since January 2015. Prior to Penumbra, Adam led SMART Therapeutics, Inc., a medical device company focused on devices for neuro-intervention, as its Chief Executive Officer from 2000 to 2002
Research Interest
has served as Chief Executive Officer and a member of our board of directors since our inception in 2004, and as President and Chairman of our board of directors since January 2015. Prior to Penumbra, Adam led SMART Therapeutics, Inc., a medical device company focused on devices for neuro-intervention, as its Chief Executive Officer from 2000 to 2002
